Here’s Why PGIM Jennison Health Sciences Fund Reduced its Position in Marinus Pharmaceuticals (MRNS)
PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Marinus Pharmaceuticals Inc. (MRNS)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Point72 Asia (Singapore) Steve Cohen | 0 | $0 | 0% | |
| 2. | Point72 (DIFC) Ltd Steve Cohen | 0 | $0 | 0% | |
| 3. | Tang Capital Management Kevin C. Tang | 0 | $0 | 0% | |
| 4. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 5. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.10 | 5,933 | $6,526.30 | 304,600 | 2024-08-14 | Filing | |
| $1.25 | 100,000 | $125,000.00 | 100,000 | 2019-12-13 | Filing | |
| $5.61 | 3,561 | $19,977.21 | 116,085 | 2015-11-06 | Filing | |
| $8.00 | 419,744 | $3,357,952.00 | 2,476,886 | 2014-08-05 | Filing | |
| $8.00 | 12,528 | $100,224.00 | 27,998 | 2014-08-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.54 | 1,600 | $864.00 | 10,900 | 2025-01-21 | Filing | |
| $0.54 | 1,610 | $869.40 | 12,490 | 2025-01-21 | Filing | |
| $1.13 | 4,657 | $5,262.41 | 79,773 | 2024-08-05 | Filing | |
| $1.14 | 3,820 | $4,354.80 | 67,406 | 2024-08-05 | Filing | |
| $1.13 | 3,621 | $4,091.73 | 60,263 | 2024-08-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q2 2024 Earnings Call Transcript
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q2 2024 Earnings Call Transcript August 13, 2024Marinus Pharmaceuticals, Inc. misses on earnings expectations.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q4 2023 Earnings Call Transcript
Marinus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.74 EPS, expectations were $-0.64. Marinus Pharmaceuticals, Inc.
5 Hyper-Growth Stocks Billionaires Are Loading Up On
This article presents an overview of the 5 Hyper-Growth Stocks Billionaires Are Loading Up On. For a detailed overview of such stocks, read our article, 11 Hyper-Growth Stocks Billionaires Are Loading...
5 Most Promising Long-Term Stocks According to Analysts
In this piece, we will take a look at the five most promising long-term stocks according to analysts.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q3 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Marinus Pharmaceuticals' Third Quarter 2023 Financial Results and Business Update Call. [Operator Instructions].
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q2 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Marinus Pharmaceuticals’ Second Quarter 2023 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q1 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Marinus Pharmaceuticals’ First Quarter 2023 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q4 2022 Earnings Call Transcript
Operator: Greetings everyone and welcome to the Marinus Pharmaceuticals' Fourth Quarter and Full-Year 2022 Financial Results and Business Update Call.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q3 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, greetings and welcome to the Marinus Pharmaceuticals' Third Quarter 2022 Financial Results and Business Update Call.
Hedge Fund Resource Center Billionaire Hedge Funds
